A-Labs Capital II Corp. ALABP.V
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -- | 405.68% | 114.12% | 466.67% | 420.00% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -- | 405.68% | 114.12% | 466.67% | 420.00% |
| Operating Income | -- | -405.68% | -114.12% | -466.67% | -420.00% |
| Income Before Tax | -- | -370.45% | -91.18% | -434.29% | -381.48% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -- | -370.45% | -91.18% | -434.29% | -381.48% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -- | -370.45% | -91.18% | -434.29% | -381.48% |
| EBIT | -- | -405.68% | -114.12% | -466.67% | -420.00% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -- | -462.79% | -92.68% | -435.29% | -384.62% |
| Normalized Basic EPS | -- | -342.31% | -117.65% | -470.00% | -387.50% |
| EPS Diluted | -- | -462.79% | -92.68% | -435.29% | -384.62% |
| Normalized Diluted EPS | -- | -342.31% | -117.65% | -470.00% | -387.50% |
| Average Basic Shares Outstanding | -- | -25.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | -- | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |